These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1221390)

  • 41. [Somatotropin secretion stimulation test for diencephalic and pituitary diseases, with special reference to the tests using arginine and insulin].
    Nakagawa K; Okamoto M; Horiuchi Y; Mashimo K
    Saishin Igaku; 1969 Nov; 24(11):2333-9. PubMed ID: 5359819
    [No Abstract]   [Full Text] [Related]  

  • 42. [Eye changes in hypothalamo-hypophyseal syndrome of the Itsenko-Cushing type].
    Gincherman EZ; Pantieleva VM; Barkman SM
    Vestn Oftalmol; 1969; ():72-5. PubMed ID: 5771468
    [No Abstract]   [Full Text] [Related]  

  • 43. [Disorders of blood coagulation in patients with hypothalamic syndrome in the puberty period and forme fruste of Itsenko-Cushing syndrome].
    Vasiukova EA; Pisarskaia IV; Sharova IuA; Skovortsova RI
    Vrach Delo; 1973 Sep; 9():73-6. PubMed ID: 4768482
    [No Abstract]   [Full Text] [Related]  

  • 44. [Serum 17-OHCS and 17-KS--in the field of internal medicine].
    Iwai K; Honda H; Tamura Y; Sako Y
    Nihon Rinsho; 1967 Aug; 25(8):1966-78. PubMed ID: 4874019
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
    Slavnov VN; Valueva GV; Luchitsky EV
    Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Electrocardiographic changes in diencephalic syndrome of the Cushing's syndrome type].
    Gincherman EZ; Slavina LS
    Probl Endokrinol (Mosk); 1968; 14(5):26-30. PubMed ID: 4310299
    [No Abstract]   [Full Text] [Related]  

  • 47. [Lipolysis in fatty tissue of patients with adrenohypercorticism].
    Tishenina RS
    Vopr Med Khim; 1983; 29(6):15-20. PubMed ID: 6322439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prostaglandins in Itsenko-Cushing syndrome].
    Slavnov VN; Iakovlev AA; Komissarenko IV
    Klin Med (Mosk); 1989 Jun; 67(6):94-8. PubMed ID: 2779163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Determination of serum (and urinary) 17-hydroxycorticosteroids and 17-ketosteroids].
    Iwai K; Honda H
    Nihon Rinsho; 1976; 34 suppl():2112-31. PubMed ID: 186650
    [No Abstract]   [Full Text] [Related]  

  • 50. [Dynamics of the glucagon and C-peptide content in Itsenko-Cushing disease].
    Arapova SD; Zavadskiĭ PS; Marova EI
    Sov Med; 1980; (2):42-7. PubMed ID: 6987746
    [No Abstract]   [Full Text] [Related]  

  • 51. [Blood ACTH levels in patients with Itsenko-Cushing disease and the effect of radiotherapy].
    Makarovskaia EE; Marova EI
    Probl Endokrinol (Mosk); 1970; 16(4):36-40. PubMed ID: 4325290
    [No Abstract]   [Full Text] [Related]  

  • 52. [Various questions concerning the genesis of Itsenko-Cushing disease].
    Soskin LS; Ravikovich MA; Bogdanovich LG; Levinson TN; Fal'chuk AIa
    Vopr Neirokhir; 1969; 33(3):14-8. PubMed ID: 5306742
    [No Abstract]   [Full Text] [Related]  

  • 53. [Binding hydrocortisone with transcortin in diencephalic syndrome following the Itsenko-Cushing disease course].
    Rozen VB; Ramikh MV; Gincherman EZ; Balakhovskaia MI
    Probl Endokrinol (Mosk); 1969; 15(3):48-52. PubMed ID: 5805906
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pituitary syndromes of diencephalic origin. Clinical application of pituitary stimulation tests].
    Ruedi B; Felber JP; Aubert M
    Schweiz Med Wochenschr; 1968 Feb; 98(5):144-8. PubMed ID: 4298598
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical neurologic and endocrinologic studies on diencephalic-hypophyseal diseases. I. Manifestations of diencephalic-hypophyseal diseases].
    Sakoda M; Oishi H
    Horumon To Rinsho; 1970 Jun; 18(6):479-86. PubMed ID: 5465000
    [No Abstract]   [Full Text] [Related]  

  • 56. [Serum prolactin, GH, TSH, LH, FSH in hypothalamo-pituitary diseases].
    Ogawa N; Yozai S; Miyoshi M; Takahara J; Ofuji T
    Horumon To Rinsho; 1975 Nov; 23(11):1133-7. PubMed ID: 1240031
    [No Abstract]   [Full Text] [Related]  

  • 57. [Insulin secretion in Itsenko-Cushing disease depending upon the expression of diabetic disorders].
    Bogatyrev OP; Kalinin AP; Tishenina RS; Zenovko EI; Gapanovich NS
    Ter Arkh; 1977; 49(5):36-9. PubMed ID: 877889
    [No Abstract]   [Full Text] [Related]  

  • 58. [Plasma 17-hydroxycorticosteroids (OHCS) and 17-ketosteroids (KS) (including urinary contents): interpretation of the test results in the field of internal medicine].
    Iwai K; Yawata M; Tamura Y; Sako Y; Honda H
    Nihon Rinsho; 1969 Mar; ():Suppl:906-20. PubMed ID: 4948301
    [No Abstract]   [Full Text] [Related]  

  • 59. [The functional state of the hypothalamo-hypophyseal system in tumors of the pituitary and diencephalic area].
    Bozadzhieva E; Savov G; Milanov S; Ovcharuva W; Platonova E
    Probl Endokrinol (Mosk); 1975; 21(2):22-7. PubMed ID: 165476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The reproductive endocrinology of childhood and adolescence.
    Pennington GW
    Clin Obstet Gynaecol; 1974 Dec; 1(3):509-31. PubMed ID: 4620626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.